LONDON (AP) — Prince Charles can be readily available Tuesday when pharmaceutical firm AstraZeneca opens a 1 billion-pound ($1.34 billion) analysis middle close to the College of Cambridge, hoping to construct on work in creating one of many first COVID-19 vaccines.
The 19,000 square-meter (greater than 200,000 square-foot) advanced will home greater than 2,200 analysis scientists. It joins a cluster of companies in search of to make Cambridge a hub for all times sciences analysis much like what California’s Silicon Valley is for the know-how business.
“Our ambition as we speak is to not solely unveil a constructing, however to additionally drive the following wave of scientific innovation,” CEO Pascal Soriot mentioned in a press release.
The Cambridge life sciences cluster consists of 631 corporations that make use of virtually 21,000 individuals and generate annual income of seven billion kilos, in keeping with Cambridge Forward, which promotes enterprise improvement within the metropolis.
AstraZeneca labored with Oxford College to develop one of many first COVID-19 vaccines authorized by regulators within the U.Okay., European Union and different international locations. The vaccine is broadly utilized in creating nations as a result of AstraZeneca has pledged to maintain prices down by promoting it to low- and middle-income international locations on a non-profit foundation.
AstraZeneca additionally plans to ask the U.S. Meals and Drug Administration to approve the vaccine.